• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.新型隐球菌非包被变异株 I. 毒力研究及可溶性多糖的特性。
Infect Immun. 1971 Feb;3(2):287-94. doi: 10.1128/iai.3.2.287-294.1971.
2
Characterization of pathogenic constituents of Cryptococcus neoformans strains.新型隐球菌菌株致病成分的特征分析
Microbiol Immunol. 1985;29(6):517-32. doi: 10.1111/j.1348-0421.1985.tb00854.x.
3
Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A.新型隐球菌A血清型荚膜多糖的组成和分子大小的菌株变异
Infect Immun. 1986 Dec;54(3):735-41. doi: 10.1128/iai.54.3.735-741.1986.
4
Immediate hypersensitivity to Cryptococcus neoformans.对新型隐球菌的速发型超敏反应。
Infect Immun. 1981 Feb;31(2):842-4. doi: 10.1128/iai.31.2.842-844.1981.
5
Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D.新型隐球菌A-D血清型荚膜多糖的化学特性分析
Microbiol Immunol. 1985;29(10):981-91. doi: 10.1111/j.1348-0421.1985.tb02962.x.
6
Cryptococcus neoformans. 3. Inhibition of phagocytosis.新型隐球菌。3. 吞噬作用的抑制。
J Bacteriol. 1968 Jan;95(1):5-8. doi: 10.1128/jb.95.1.5-8.1968.
7
Binding of purified and radioiodinated capsular polysaccharides from Cryptococcus neoformans serotype A strains to capsule-free mutants.新型隐球菌A血清型菌株纯化及放射性碘化荚膜多糖与无荚膜突变体的结合
Infect Immun. 1986 Dec;54(3):742-50. doi: 10.1128/iai.54.3.742-750.1986.
8
Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.新型隐球菌的非包膜变种。II. 隐球菌多糖的表面受体及其在多糖抑制吞噬作用中的作用。
Infect Immun. 1977 Apr;16(1):99-106. doi: 10.1128/iai.16.1.99-106.1977.
9
Binding of cryptococcal polysaccharide to Cryptococcus neoformans.隐球菌多糖与新型隐球菌的结合。
Infect Immun. 1984 Mar;43(3):879-86. doi: 10.1128/iai.43.3.879-886.1984.
10
In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.一种能引发保护性抗体的新型隐球菌葡糖醛酸木甘露聚糖表位在体外和体内的稳定性[已修正]
Infect Immun. 1999 Jun;67(6):3096-107. doi: 10.1128/IAI.67.6.3096-3107.1999.

引用本文的文献

1
A Quick reCAP: Discovering Capsule Mutants.快速回顾:发现胶囊突变体。
J Fungi (Basel). 2024 Jan 30;10(2):114. doi: 10.3390/jof10020114.
2
Antifungal Peptide SP1 Damages Polysaccharide Capsule of Cryptococcus neoformans and Enhances Phagocytosis of Macrophages.抗真菌肽SP1破坏新型隐球菌的多糖荚膜并增强巨噬细胞的吞噬作用。
Microbiol Spectr. 2023 Mar 14;11(2):e0456222. doi: 10.1128/spectrum.04562-22.
3
Phenotypic Plasticity in the Productions of Virulence Factors Within and Among Serotypes in the Cryptococcus neoformans Species Complex.新型隐球菌种复合体中血清型内和血清型间毒力因子产生的表型可塑性。
Mycopathologia. 2022 Feb;187(1):65-83. doi: 10.1007/s11046-021-00597-3. Epub 2021 Oct 25.
4
Cryptococcus neoformans Rim101 is associated with cell wall remodeling and evasion of the host immune responses.新生隐球菌 Rim101 与细胞壁重塑和逃避宿主免疫反应有关。
mBio. 2013 Jan 15;4(1):e00522-12. doi: 10.1128/mBio.00522-12.
5
Intracellular cryptococci suppress Fc-mediated cyclin D1 elevation.细胞内隐球菌抑制Fc介导的细胞周期蛋白D1升高。
Commun Integr Biol. 2010 Jul;3(4):390-1. doi: 10.4161/cib.3.4.12090.
6
Immune restoration diseases reflect diverse immunopathological mechanisms.免疫重建疾病反映了不同的免疫病理机制。
Clin Microbiol Rev. 2009 Oct;22(4):651-63. doi: 10.1128/CMR.00015-09.
7
Phenotypic heterogeneity in expression of epitopes in the Cryptococcus neoformans capsule.新型隐球菌荚膜中表位表达的表型异质性。
Mol Microbiol. 2009 Oct;74(1):126-138. doi: 10.1111/j.1365-2958.2009.06855.x. Epub 2009 Sep 2.
8
Expression of capsule-associated genes of Cryptococcus neoformans.新型隐球菌荚膜相关基因的表达
Mycopathologia. 2005 Aug;160(1):1-7. doi: 10.1007/s11046-005-0139-6.
9
Role of phagocytosis in the virulence of Cryptococcus neoformans.吞噬作用在新型隐球菌毒力中的作用。
Eukaryot Cell. 2004 Oct;3(5):1067-75. doi: 10.1128/EC.3.5.1067-1075.2004.
10
Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes.初级树突状细胞通过甘露糖受体和Fcγ受体II吞噬新型隐球菌,以呈递给T淋巴细胞。
Infect Immun. 2002 Nov;70(11):5972-81. doi: 10.1128/IAI.70.11.5972-5981.2002.

本文引用的文献

1
Cryptococcus neoformans IV. The Not-So-Encapsulated Yeast.新型隐球菌 IV. 非包裹酵母菌。
Infect Immun. 1970 Jun;1(6):526-31. doi: 10.1128/iai.1.6.526-531.1970.
2
The use of gastric mucin to lower resistance of laboratory animals to systemic fungus infections.使用胃粘蛋白降低实验动物对全身性真菌感染的抵抗力。
J Infect Dis. 1951 Mar-Apr;88(2):151-5. doi: 10.1093/infdis/88.2.151.
3
Isolation of a dry variant from a mucoid strain of Cryptococcus neoformas and preliminary comparative studies.从新型隐球菌黏液样菌株中分离出干燥变种并进行初步比较研究。
J Bacteriol. 1962 Apr;83(4):926-8. doi: 10.1128/jb.83.4.926-928.1962.
4
CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION.新型隐球菌多糖:血清学特性及其在感染中作用的研究
J Immunol. 1965 Jun;94:916-20.
5
NATURAL HOST RESISTANCE TO INFECTION WITH CRYPTOCOCCUS NEOFORMANS. III. THE EFFECT OF CRYPTOCOCCAL POLYSACCHARIDE UPON THE PHYSIOLOGY OF THE RETICULOENDOTHELIAL SYSTEM OF LABORATORY ANIMALS.天然宿主对新型隐球菌感染的抵抗力。III. 隐球菌多糖对实验动物网状内皮系统生理学的影响。
J Infect Dis. 1964 Feb;114:95-106. doi: 10.1093/infdis/114.1.95.
6
Taxonomy of Cryptococcus neoformans and its variety uniguttulatus.新型隐球菌及其单孢变种的分类学
Antonie Van Leeuwenhoek. 1961;27:59-64. doi: 10.1007/BF02538423.
7
Studies of proteins and antibodies by specific hemagglutination and hemolysis of proteinconjugated erythrocytes.通过蛋白质结合红细胞的特异性血凝和溶血对蛋白质及抗体进行研究。
Int Arch Allergy Appl Immunol. 1958;13(1-2):1-38. doi: 10.1159/000228473.
8
The genus Cryptococcus.隐球菌属。
Bacteriol Rev. 1956 Sep;20(3):189-201. doi: 10.1128/br.20.3.189-201.1956.
9
The antigenic compostion of Cryptococcus neoformans. IV. The use of paper chromatography for following purification of the capsular polysaccharide.新型隐球菌的抗原组成。IV. 利用纸色谱法追踪荚膜多糖的纯化过程。
J Bacteriol. 1953 May;65(5):571-7. doi: 10.1128/jb.65.5.571-577.1953.
10
Cryptococcosis due to an unusually slow-growing organism.由一种生长异常缓慢的生物体引起的隐球菌病。
Am J Med Technol. 1967 Sep-Oct;33(5):397-9.

新型隐球菌非包被变异株 I. 毒力研究及可溶性多糖的特性。

Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.

机构信息

Department of Microbiology, University of Iowa, Iowa City, Iowa 52240.

出版信息

Infect Immun. 1971 Feb;3(2):287-94. doi: 10.1128/iai.3.2.287-294.1971.

DOI:10.1128/iai.3.2.287-294.1971
PMID:16557967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC416145/
Abstract

A weakly virulent nonencapsulated variant of Cryptococcus neoformans is described. The chemical structure and antigenicity of the soluble polysaccharides produced by the variant strain and a typical virulent strain were compared. The soluble polysaccharides produced by both strains were composed of the same constituent monosaccharides; however, the virulent strain produced a polysaccharide having a greater uronic acid content and a larger molecular size than that of the variant strain. Soluble polysaccharides from the two strains are not closely related immunologically. Soluble polysaccharide obtained from the virulent strain did not affect persistence of the variant strain in mice.

摘要

现描述了一种新型隐球菌的弱毒非荚膜变异株。比较了变异株和典型毒力株所产生的可溶性多糖的化学结构和抗原性。两株菌所产生的可溶性多糖均由相同的单糖组成;然而,毒力株所产生的多糖的酸性多糖含量和分子量均大于变异株。两株菌的可溶性多糖在免疫学上没有密切的关系。从毒力株获得的可溶性多糖不会影响变异株在小鼠体内的持续存在。